Related Experiment Videos
Clinical implications of enzyme induction and enzyme inhibition
Abstract:
The pharmacological effect of a drug is partly dependent upon its concentration at its site of action, which in turn is partly dependent upon its rate of elimination. The rate of elimination of many lipophilic drugs is governed by the activity of the hepatic microsomal mixed-function oxidases. Consequently any alteration in the activity of these enzymes may result in a modification of drug action. A wide range of chemically unrelated substances may stimulate the activity of the mixed-function oxidases by enzyme induction. The drugs most frequently encountered as enzyme-inducing agents in man are barbiturates, rifampicin and phenytoin. Enhancement of drug metabolism by ethanol, tobacco smoking and diet may also involve enzyme induction. Enzyme induction is normally associated with a reduction in the drug efficacy but may also alter the toxicity of certain substances. Enzyme induction has been assessed in man by measuring changes in the pharmacokinetics of a marker drug, or changes in the disposition of endogenous compounds such as gamma-glutamyltranspeptidase, D-glucaric acid and 6beta-hydroxycortisol. The therapeutic problems associated with enzyme inhibition have received much less attention than those associated with enzyme induction. The effect on the rate of elimination of a particular drug will depend upon the fraction of the dose that is normally metabolised by the inhibited enzyme and on the affinity of the enzyme for the drug and the inhibitor. An alteration in the dosage schedule is usually only necessary for drugs with a small therapeutic ratio.
Insights
Drug-metabolizing enzyme activity, particularly hepatic microsomal mixed-function oxidases, significantly impacts drug efficacy and toxicity. Enzyme induction or inhibition by various substances can alter drug concentrations and therapeutic outcomes.
Area of Science:
- Pharmacology
- Drug Metabolism
- Enzyme Kinetics
Background:
- Drug's pharmacological effect is linked to its concentration at the site of action, influenced by elimination rate.
- Hepatic microsomal mixed-function oxidases (HM-MFOs) govern the elimination of many lipophilic drugs.
- Altered HM-MFOs activity can modify drug action, efficacy, and toxicity.
Purpose of the Study:
- To explore the impact of enzyme induction and inhibition on drug elimination and pharmacological effects.
- To highlight the clinical relevance of understanding drug-metabolizing enzyme modulation.
Main Methods:
- Review of literature on enzyme induction and inhibition affecting drug metabolism.
- Discussion of methods for assessing enzyme induction in humans, including marker drugs and endogenous compounds.
- Analysis of factors influencing drug elimination rate under enzyme inhibition.
Main Results:
- Enzyme induction by substances like barbiturates, rifampicin, and phenytoin can reduce drug efficacy but may also alter toxicity.
- Ethanol, tobacco, and diet can also induce HM-MFOs, affecting drug metabolism.
- Enzyme inhibition's therapeutic problems are less studied but depend on the fraction of dose metabolized and enzyme affinity.
Conclusions:
- Modulation of HM-MFOs activity through enzyme induction or inhibition significantly impacts drug pharmacokinetics and pharmacodynamics.
- Understanding these interactions is crucial for optimizing drug therapy, especially for drugs with a narrow therapeutic index.